Mistletoe lectins: From interconnecting proteins to potential tumour inhibiting agents
Authors:
- Mahak MajeedMMMahak Majeed
- Khalid Rehman HakeemKhalid Rehman Hakeem
- Reiaz Ul RehmanRRReiaz Ul Rehman
Open Access
- 1 August 2021
- journal article
- Published by Elsevier in Phytomedicine Plus
- Vol. 1 (3)
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Could plant lectins become promising anti‐tumour drugs for causing autophagic cell death?Cell Proliferation, 2013
- Recombinant VAA-I from Viscum album Induces Apoptotic Cell Death of Hepatocellular Carcinoma SMMC7721 CellsMolecules, 2012
- Down‐regulation of some miRNAs by degrading their precursors contributes to anti‐cancer effect of mistletoe lectin‐IBritish Journal of Pharmacology, 2010
- Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical researchJournal of Experimental & Clinical Cancer Research, 2009
- Viscum album agglutinin‐I induces degradation of cytoskeletal proteins in leukaemia PLB‐985 cells differentiated toward neutrophils: cleavage of non‐muscle myosin heavy chain‐IIA by caspasesBritish Journal of Haematology, 2007
- Silver staining of proteins in polyacrylamide gelsNature Protocols, 2006
- Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development GroupAnnals of Oncology, 2004
- Antitumor activity of Cratylia mollis lectin encapsulated into liposomesInternational Journal of Pharmaceutics, 2004
- Complete structure determination of the A chain of mistletoe lectin III fromViscum albumL. ssp.albumJournal of Peptide Science, 2003
- Crystal Structure of Mistletoe Lectin I fromViscum albumBiochemical and Biophysical Research Communications, 1999